Epigenetic biomarkers – Promising tools for prostate cancer

Speaker: Dr. Bharati Bapat
Original Date: Tuesday, January 26, 2016

Join Dr. Bapat as she describes:

  • What is Epigenetics
  • The interplay between epigenetics & genetics, and epigenetics & environment
  • What are different types of epigenetic biomarkers
  • How these markers will help prostate cancer patients

Dr. Bharati Bapat's Biography:

Dr. Bharati Bapat is Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and has scientific appointments at the Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital, and the Department of Laboratory Medicine and Pathology, University Health Network. 
Dr. Bapat’s research program is focused on translational genomics and epigenomics, specifically the discovery of cancer biomarkers, and understanding their role in cancer development.  Dr. Bapat is involved in several national and international collaborative prostate cancer research projects to develop biomarkers for personalized medicine using less invasive strategies to obtain patient samples. She is currently leading PCC funded Movember Translation Acceleration Grant (TAG) for validation of epigenetic biomarker panels for early detection of aggressive prostate cancer.  Dr. Bapat’s team is participating in Movember Global Action Plan (GAP) biomarker projects, aimed at making discoveries at a faster pace to help patients and their families.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive